Implanet Presents The Clinical Results Of Its JAZZ Implant In Adolescent Scoliosis Surgery

BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext: IMPL, FR0010458729, PEA-PME eligible) (Paris:IMPL), a medical technology company specializing in vertebral and knee-surgery implants, today announces the publication of the “Adolescent Idiopathic Scoliosis Treated by Posteromedial Translation Using Jazz Sublaminar Bands” White Paper available on www.implanet.com.

This study, carried out by the Department of Pediatric Orthopedic Surgery at the Robert Debré hospital, which is part of Paris Diderot University, includes details of the results obtained with the help of the JAZZ implant in the surgical treatment of adolescent idiopathic scoliosis by posteromedial translation, in particular in terms of the restoration of frontal and sagittal alignment. The study was conducted with 12-month follow-up of a consecutive series of 20 patients.

Help employers find you! Check out all the jobs and post your resume.